Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This study will examine the efficacy and safety of HLD200 (methylphenidate) in patients age 6-12 years with ADHD. This study has a 6-week dose optimization period followed by a one week double blind randomization assessment.
Critère d'inclusion
- Attention Deficit Hyperactivity Disorder